Cite
HARVARD Citation
Ettrich, T. et al. (n.d.). 564PTRICC-C: Nintedanib vs. placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: Final results from the randomized phase II trial of the AIO. Annals of oncology. p. . [Online].